BR0215394A - Polissacarìdeo negativamente carregado derivável de aloe vera - Google Patents

Polissacarìdeo negativamente carregado derivável de aloe vera

Info

Publication number
BR0215394A
BR0215394A BR0215394-7A BR0215394A BR0215394A BR 0215394 A BR0215394 A BR 0215394A BR 0215394 A BR0215394 A BR 0215394A BR 0215394 A BR0215394 A BR 0215394A
Authority
BR
Brazil
Prior art keywords
aloe vera
negatively charged
matter
composition
polysaccharide derived
Prior art date
Application number
BR0215394-7A
Other languages
English (en)
Other versions
BR0215394B1 (pt
BRPI0215394B8 (pt
Inventor
Willem Van Dijk
Annelize Frieda Goedbloed
Floris Jan Robbert Koumans
Original Assignee
2Qr Res Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 2Qr Res Bv filed Critical 2Qr Res Bv
Publication of BR0215394A publication Critical patent/BR0215394A/pt
Publication of BR0215394B1 publication Critical patent/BR0215394B1/pt
Publication of BRPI0215394B8 publication Critical patent/BRPI0215394B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5424—Polymers characterized by specific structures/properties characterized by the charge anionic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

"POLISSACARìDEO NEGATIVAMENTE CARREGADO DERIVáVEL DE ALOE VERA". A presente invenção refere-se a uma nova composição de matéria é fornecida compreendendo polissacarídeos negativamente carregados que podem ser derivados de Aloe vera e um processo para preparar essa composição de matéria por subfracionamento de um extrato de Aloe vera, passando a subfração formada em uma coluna positivamente carregada e eluindo a mesma com uma solução de sal. Opcionalmente, Aloe vera é pré-purificada em uma coluna de Sephadex G-25. Esta composição de matéria e também o extrato compreendendo a mesma que é formada depois da pré-purificação ou ultrafiltração de um extrato de Aloe vera é útil como um suplemento alimentar ou em alimentos dietéticos, para uso em cuidado pessoal e em cosméticos, especialmente para prevenir uma infecção com as bactérias Helicobacter pylori, Pseudomonas aeruginosa, Streptococcus mutans ou Streptococcus sanguis.
BRPI0215394A 2001-12-27 2002-12-23 composição compreendendo polissacarídeos deriváveis de aloe vera, extrato nag-25, extrato ultrafiltrado de aloe, seus processos de preparação, suas formas de dosagens, e seus usos BRPI0215394B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01205253.6 2001-12-27
EP01205253A EP1323738A1 (en) 2001-12-27 2001-12-27 Negatively charged polysaccharide derivable form Aloe Vera
PCT/NL2002/000868 WO2003055918A1 (en) 2001-12-27 2002-12-23 Negatively charged polysaccharide derivable from aloe vera

Publications (3)

Publication Number Publication Date
BR0215394A true BR0215394A (pt) 2005-04-05
BR0215394B1 BR0215394B1 (pt) 2014-07-22
BRPI0215394B8 BRPI0215394B8 (pt) 2021-05-25

Family

ID=8181567

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0215394A BRPI0215394B8 (pt) 2001-12-27 2002-12-23 composição compreendendo polissacarídeos deriváveis de aloe vera, extrato nag-25, extrato ultrafiltrado de aloe, seus processos de preparação, suas formas de dosagens, e seus usos

Country Status (11)

Country Link
US (1) US8628807B2 (pt)
EP (2) EP1323738A1 (pt)
JP (1) JP4509564B2 (pt)
AT (1) ATE366750T1 (pt)
AU (1) AU2002358351B2 (pt)
BR (1) BRPI0215394B8 (pt)
CA (1) CA2471679A1 (pt)
DE (1) DE60221155T2 (pt)
ES (1) ES2290350T3 (pt)
HR (1) HRP20040586A2 (pt)
WO (1) WO2003055918A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2224881B1 (es) * 2003-08-26 2006-07-16 Universidad De Alcala Procedimiento mejorado para el fraccionamiento de principios activos de hojas de aloe.
GB0426068D0 (en) * 2004-11-29 2004-12-29 Passion For Life Healthcare Lt Composition with bacteria blocking action
US7678886B2 (en) 2005-01-07 2010-03-16 Xencor, Inc. Pharmaceutical compositions of adiponectin variants and methods of storage
NL2001386C2 (nl) * 2008-03-18 2008-11-25 Novaclin B V Huidverzorgingsproduct en gebruik van een copolymeer van galactoarabinaan en polyglucuronzuur voor de vervaardiging daarvan.
CN101392033B (zh) * 2008-11-03 2011-12-21 中国烟草总公司郑州烟草研究院 芦荟多糖提取方法及其在卷烟中的应用
WO2013050432A2 (en) 2011-10-05 2013-04-11 Multi Oral Bv Method for oral care
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
US10449143B2 (en) 2014-04-17 2019-10-22 Conopco, Inc. Aloe vera extract for personal care compositions
CN106456524B (zh) 2014-04-17 2019-12-10 荷兰联合利华有限公司 个人护理组合物
IT201700122874A1 (it) * 2017-10-31 2019-05-01 Roberto Leone Composizione edibile a base di bava di lumaca per la conservazione degli alimenti e per la sanificazione di superfici, ambienti e strumenti
WO2019124075A1 (ja) 2017-12-19 2019-06-27 森永乳業株式会社 アロエ粉末の製造方法
KR102071668B1 (ko) * 2018-04-04 2020-01-30 주식회사 엘지생활건강 한약재 추출물 또는 이의 분획물을 포함하는 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물
CN111494285A (zh) * 2020-06-04 2020-08-07 珠海萱嘉君行健康产业发展有限公司 一种基于芦荟皮或芦荟废水提取抑菌物质的方法及其应用
WO2022046975A1 (en) * 2020-08-28 2022-03-03 Herbalife International Of America, Inc. Compositions comprising neutral and acidic polysaccharides of aloe vera and their uses
CA3198918A1 (en) 2020-10-21 2022-04-28 2Qr Research B.V. Aloe extracts for microbial neutralisation
CN113563491A (zh) * 2021-09-01 2021-10-29 重庆化工职业学院 一种芦荟多糖的提取方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297511A (pt) * 1956-12-20
US3360511A (en) * 1966-11-22 1967-12-26 Farkas Alexander Aloe polysaccharide composition and its preparation
ZA793769B (en) * 1978-07-25 1981-02-25 Wellcome Found Pharmaceutical formulation of guar gum
US4861761A (en) * 1984-06-28 1989-08-29 Dr. Madis Laboratories, Inc. Aloeferon isolation, manufacturing and its applications
JPS63501221A (ja) * 1985-06-28 1988-05-12 カ−リントン　ラボラトリ−ズ　インコ−ポレ−テツド アロエ製品の製造方法、該方法によって得られた製品およびその組成物
US5902796A (en) * 1995-09-22 1999-05-11 Carrington Laboratories, Inc. Bioactive factors of aloe vera plants
JP3677376B2 (ja) * 1996-08-13 2005-07-27 武田薬品工業株式会社 医薬
US5824659A (en) * 1996-09-04 1998-10-20 Board Of Regents, The University Of Texas System Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation
EP1036187A4 (en) * 1997-10-10 2002-03-27 Univera Pharm Inc METHOD FOR PRODUCING IMMUNOMODULATING POLYSACCHARIDES FROM ALOL
US6290964B1 (en) * 1998-03-06 2001-09-18 Kathleen Shupe Antimicrobial agents isolated from aloe vera
US6395311B2 (en) * 1998-04-29 2002-05-28 Univera Pharmaceuticals, Inc. Multicomponent biological vehicle
WO2000041541A2 (en) * 1999-01-12 2000-07-20 Vito-Mannan Polysaccharide L.L.C. Method of isolating mucilaginous polysaccharides and uses thereof

Also Published As

Publication number Publication date
JP4509564B2 (ja) 2010-07-21
JP2005524617A (ja) 2005-08-18
AU2002358351A1 (en) 2003-07-15
AU2002358351B2 (en) 2008-06-05
ES2290350T3 (es) 2008-02-16
DE60221155T2 (de) 2008-03-20
BR0215394B1 (pt) 2014-07-22
EP1461361A1 (en) 2004-09-29
EP1461361B1 (en) 2007-07-11
EP1323738A1 (en) 2003-07-02
US8628807B2 (en) 2014-01-14
ATE366750T1 (de) 2007-08-15
CA2471679A1 (en) 2003-07-10
DE60221155D1 (de) 2007-08-23
WO2003055918A1 (en) 2003-07-10
HRP20040586A2 (en) 2005-02-28
US20050019433A1 (en) 2005-01-27
BRPI0215394B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
BR0215394A (pt) Polissacarìdeo negativamente carregado derivável de aloe vera
WO1991005754A3 (fr) Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophiques et cytoprotectrices, et compositions pharmaceutiques les contenant
BRPI0415699A (pt) uso de oligossacarìdeo ácido e de oligossacarìdeo neutro, e, composições alimentìcia e lìquida
BRPI0417370A (pt) composições de produtos botánicos marinhos para proporcionar nutrição a pele danificada por envelhecimento e meio ambiente
WO2003088808A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA02004933A (es) Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
WO2003024392A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003000113A3 (en) Compositions and methods for the diagnosis and treatment of tumor
IL172773A (en) Formulations for the treatment of arthritis conditions
DE60229431D1 (de) Verwendungen von chitosanoligosacchariden
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor
BRPI0313082B8 (pt) "processo para preparação de extrato de raiz de echinacea angustifólia e uso do extrato assim obtido para preparação de composições farmacêuticas ou nutracêuticas e suplementos alimentícios".
IL145557A (en) Immunoabsorber for use in sepsis therapy
PT942741E (pt) Composicoes de lectina e suas utilizacoes
WO2004024063A3 (en) Compositions and methods for the diagnosis and treatment of tumor
ATE235885T1 (de) Antioxidative hautpflegemittel
MXPA02004934A (es) Composiciones cosmeticas conteniendo extracto de anis y retinoides.
WO2004096124A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002072035A3 (en) Novel anti-inflammatory compositions and methods of use
WO2003080568A3 (en) Probucol derivatives
CA2534961A1 (en) Process for the recovery of a phytolipid composition
ATE309781T1 (de) Verwendung eines iridaceae-extrakts in einer zusammensetzung für die stimulierung der immunabwehr
ES2184640A1 (es) Conjugados de flavanoles y cisteina.
WO2003103625A3 (en) DERMOCOSMETIC TREATMENT WITH METABOLIC PHOSPHOLIPIDS
MD1848F1 (en) Prophylactic-curative food product with pectin (variants)

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/07/2014, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Free format text: "PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C08B 37/00

Ipc: C08B 37/00 (2006.01), A23L 33/105 (2016.01), A61K

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C08B 37/00; A61K 31/715; A61K 35/78; A61K 31/736.

Ipc: C08B 37/00 (2006.01), A23L 33/105 (2016.01), A61K

B25G Requested change of headquarter approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/12/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2650 DE 19-10-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.